Topics

FDA-approved drug can repair gut leakiness in types of bowel disease

06:16 EST 5 Dec 2019 | Pharmafile

A team of biomedical scientists at the University of California has found that a FDA-approved drug for treating rheumatoid arthritis and ulcerative colitis can repair permeability in the gut’s epithelium.

The drug, Xeljanz, (tofacitinib) is used to treat ulcerative colitis, a type of chronic inflammatory bowel disease of the large intestine in which the lining of the colon becomes leaky. This affects one million Americans. The drug can also treat rheumatoid arthritis.

read more

Original Article: FDA-approved drug can repair gut leakiness in types of bowel disease

NEXT ARTICLE

More From BioPortfolio on "FDA-approved drug can repair gut leakiness in types of bowel disease"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...